APO RESEARCH · REPORT
Intranasal Drug Delivery Devices
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
Product & engineering
Understand the product.
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
Selected research
Industry Research
Intranasal Drug Delivery Devices Industry Research Report 2026
Market perspective
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
North America is the largest region of Intranasal Drug Delivery Devices, with a market share about 40%. It was followed by Europe with 35%. BD, AptarGroup, 3M Company, Teleflex, H&T Presspart and Bespak are the top 6 manufacturers of industry, and they had about 85% combined market share.
Report Scope
Read the full market overview
This report quantifies the global Intranasal Drug Delivery Devices market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Intranasal Drug Delivery Devices Market by Company
BD
AptarGroup
3M
Teleflex
H＆T Presspart
Bespak
Intranasal Drug Delivery Devices Segment by Type
Multidose
Uni/bidose
Intranasal Drug Delivery Devices Segment by Application
Personal Use
Hospital Use
Intranasal Drug Delivery Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intranasal Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intranasal Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intranasal Drug Delivery Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Intranasal Drug Delivery Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Intranasal Drug Delivery Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Intranasal Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Multidose
- Uni/bidose
Applications
- Personal Use
- Hospital Use
Companies covered
- BD
- AptarGroup
- 3M
- Teleflex
- H＆T Presspart
- Bespak
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Intranasal Drug Delivery Devices Market Size (2021-2032)
- 2.2.2 Global Intranasal Drug Delivery Devices Sales (2021-2032)
- 2.2.3 Global Intranasal Drug Delivery Devices Market Average Price (2021-2032)
- 2.3 Intranasal Drug Delivery Devices by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Multidose
- 2.3.3 Uni/bidose
- 2.4 Intranasal Drug Delivery Devices by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Personal Use
- 2.4.3 Hospital Use
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Intranasal Drug Delivery Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Intranasal Drug Delivery Devices Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Intranasal Drug Delivery Devices Revenue of Manufacturers (2021-2026)
- 3.4 Global Intranasal Drug Delivery Devices Average Price by Manufacturers (2021-2026)
- 3.5 Global Intranasal Drug Delivery Devices Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Intranasal Drug Delivery Devices, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Intranasal Drug Delivery Devices, Product Type & Application
- 3.8 Global Manufacturers of Intranasal Drug Delivery Devices, Established Date
- 3.9 Global Intranasal Drug Delivery Devices Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BD
- 4.1.1 BD Company Information
- 4.1.2 BD Business Overview
- 4.1.3 BD Intranasal Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 BD Intranasal Drug Delivery Devices Product Portfolio
- 4.1.5 BD Recent Developments
- 4.2 AptarGroup
- 4.2.1 AptarGroup Company Information
- 4.2.2 AptarGroup Business Overview
- 4.2.3 AptarGroup Intranasal Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AptarGroup Intranasal Drug Delivery Devices Product Portfolio
- 4.2.5 AptarGroup Recent Developments
- 4.3 3M
- 4.3.1 3M Company Information
- 4.3.2 3M Business Overview
- 4.3.3 3M Intranasal Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 3M Intranasal Drug Delivery Devices Product Portfolio
- 4.3.5 3M Recent Developments
- 4.4 Teleflex
- 4.4.1 Teleflex Company Information
- 4.4.2 Teleflex Business Overview
- 4.4.3 Teleflex Intranasal Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teleflex Intranasal Drug Delivery Devices Product Portfolio
- 4.4.5 Teleflex Recent Developments
- 4.5 H＆T Presspart
- 4.5.1 H＆T Presspart Company Information
- 4.5.2 H＆T Presspart Business Overview
- 4.5.3 H＆T Presspart Intranasal Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 H＆T Presspart Intranasal Drug Delivery Devices Product Portfolio
- 4.5.5 H＆T Presspart Recent Developments
- 4.6 Bespak
- 4.6.1 Bespak Company Information
- 4.6.2 Bespak Business Overview
- 4.6.3 Bespak Intranasal Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bespak Intranasal Drug Delivery Devices Product Portfolio
- 4.6.5 Bespak Recent Developments
5 Global Intranasal Drug Delivery Devices Market Scenario by Region
- 5.1 Global Intranasal Drug Delivery Devices Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Intranasal Drug Delivery Devices Sales by Region: 2021-2032
- 5.2.1 Global Intranasal Drug Delivery Devices Sales by Region: 2021-2026
- 5.2.2 Global Intranasal Drug Delivery Devices Sales by Region: 2027-2032
- 5.3 Global Intranasal Drug Delivery Devices Revenue by Region: 2021-2032
- 5.3.1 Global Intranasal Drug Delivery Devices Revenue by Region: 2021-2026
- 5.3.2 Global Intranasal Drug Delivery Devices Revenue by Region: 2027-2032
- 5.4 North America Intranasal Drug Delivery Devices Market Facts & Figures by Country
- 5.4.1 North America Intranasal Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Intranasal Drug Delivery Devices Sales by Country (2021-2032)
- 5.4.3 North America Intranasal Drug Delivery Devices Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Intranasal Drug Delivery Devices Market Facts & Figures by Country
- 5.5.1 Europe Intranasal Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Intranasal Drug Delivery Devices Sales by Country (2021-2032)
- 5.5.3 Europe Intranasal Drug Delivery Devices Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Intranasal Drug Delivery Devices Market Facts & Figures by Country
- 5.6.1 Asia Pacific Intranasal Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Intranasal Drug Delivery Devices Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Intranasal Drug Delivery Devices Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Intranasal Drug Delivery Devices Market Facts & Figures by Country
- 5.7.1 South America Intranasal Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Intranasal Drug Delivery Devices Sales by Country (2021-2032)
- 5.7.3 South America Intranasal Drug Delivery Devices Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Intranasal Drug Delivery Devices Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Intranasal Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Intranasal Drug Delivery Devices Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Intranasal Drug Delivery Devices Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Intranasal Drug Delivery Devices Sales by Type (2021-2032)
- 6.1.1 Global Intranasal Drug Delivery Devices Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Intranasal Drug Delivery Devices Sales Market Share by Type (2021-2032)
- 6.2 Global Intranasal Drug Delivery Devices Revenue by Type (2021-2032)
- 6.2.1 Global Intranasal Drug Delivery Devices Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Intranasal Drug Delivery Devices Revenue Market Share by Type (2021-2032)
- 6.3 Global Intranasal Drug Delivery Devices Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Intranasal Drug Delivery Devices Sales by Application (2021-2032)
- 7.1.1 Global Intranasal Drug Delivery Devices Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Intranasal Drug Delivery Devices Sales Market Share by Application (2021-2032)
- 7.2 Global Intranasal Drug Delivery Devices Revenue by Application (2021-2032)
- 7.2.1 Global Intranasal Drug Delivery Devices Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Intranasal Drug Delivery Devices Revenue Market Share by Application (2021-2032)
- 7.3 Global Intranasal Drug Delivery Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Intranasal Drug Delivery Devices Value Chain Analysis
- 8.1.1 Intranasal Drug Delivery Devices Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Intranasal Drug Delivery Devices Production Mode & Process
- 8.2 Intranasal Drug Delivery Devices Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Intranasal Drug Delivery Devices Distributors
- 8.2.3 Intranasal Drug Delivery Devices Customers
9 Global Intranasal Drug Delivery Devices Analyzing Market Dynamics
- 9.1 Intranasal Drug Delivery Devices Industry Trends
- 9.2 Intranasal Drug Delivery Devices Industry Drivers
- 9.3 Intranasal Drug Delivery Devices Industry Opportunities and Challenges
- 9.4 Intranasal Drug Delivery Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst